Annual Operating Profit
-$13.32 M
+$6.39 M+32.42%
01 December 2023
Summary:
Plus Therapeutics annual operaing income is currently -$13.32 million, with the most recent change of +$6.39 million (+32.42%) on 01 December 2023. During the last 3 years, it has fallen by -$3.74 million (-38.99%). PSTV annual operating profit is now -547.59% below its all-time high of -$2.06 million, reached on 31 December 1998.PSTV Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$3.80 M
-$102.00 K-2.76%
01 September 2024
Summary:
Plus Therapeutics quarterly operating income is currently -$3.80 million, with the most recent change of -$102.00 thousand (-2.76%) on 01 September 2024. Over the past year, it has increased by +$59.00 thousand (+1.53%). PSTV quarterly operating profit is now -185.29% below its all-time high of $4.45 million, reached on 31 December 2006.PSTV Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$14.65 M
-$548.00 K-3.89%
01 September 2024
Summary:
Plus Therapeutics TTM operating income is currently -$14.65 million, with the most recent change of -$548.00 thousand (-3.89%) on 01 September 2024. Over the past year, it has dropped by -$1.33 million (-10.00%). PSTV TTM operating profit is now -336.75% below its all-time high of -$3.35 million, reached on 30 September 2019.PSTV TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +1.5% | -10.0% |
| 3 y3 years | -39.0% | -9.1% | -22.8% |
| 5 y5 years | -52.0% | -241.8% | -336.8% |
PSTV Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.0% | +32.4% | -155.0% | +31.8% | -23.2% | +28.6% |
| 5 y | 5 years | -264.3% | +32.4% | -241.8% | +31.8% | -336.8% | +28.6% |
| alltime | all time | -547.6% | +60.0% | -185.3% | +76.3% | -336.8% | +63.5% |
Plus Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.80 M(+2.8%) | -$14.65 M(+3.9%) |
| June 2024 | - | -$3.70 M(+12.1%) | -$14.11 M(+18.5%) |
| Mar 2024 | - | -$3.30 M(-14.5%) | -$11.90 M(-10.7%) |
| Dec 2023 | -$13.32 M(-32.4%) | -$3.86 M(+18.7%) | -$13.32 M(-11.4%) |
| Sept 2023 | - | -$3.25 M(+118.2%) | -$15.04 M(-10.9%) |
| June 2023 | - | -$1.49 M(-68.4%) | -$16.88 M(-17.7%) |
| Mar 2023 | - | -$4.72 M(-15.3%) | -$20.51 M(+4.0%) |
| Dec 2022 | -$19.71 M(+58.6%) | -$5.57 M(+9.4%) | -$19.71 M(+9.3%) |
| Sept 2022 | - | -$5.09 M(-0.5%) | -$18.03 M(+9.8%) |
| June 2022 | - | -$5.12 M(+30.4%) | -$16.42 M(+18.3%) |
| Mar 2022 | - | -$3.93 M(+0.9%) | -$13.87 M(+11.6%) |
| Dec 2021 | -$12.43 M(+29.7%) | -$3.89 M(+11.8%) | -$12.43 M(+4.2%) |
| Sept 2021 | - | -$3.48 M(+35.2%) | -$11.93 M(+21.2%) |
| June 2021 | - | -$2.58 M(+3.9%) | -$9.85 M(+2.3%) |
| Mar 2021 | - | -$2.48 M(-27.0%) | -$9.62 M(+0.4%) |
| Dec 2020 | -$9.58 M(+162.1%) | -$3.40 M(+143.2%) | -$9.58 M(+14.1%) |
| Sept 2020 | - | -$1.40 M(-40.6%) | -$8.40 M(+94.2%) |
| June 2020 | - | -$2.35 M(-3.6%) | -$4.33 M(+10.0%) |
| Mar 2020 | - | -$2.44 M(+10.3%) | -$3.93 M(+7.5%) |
| Dec 2019 | -$3.66 M(-58.3%) | -$2.21 M(-182.6%) | -$3.66 M(+9.0%) |
| Sept 2019 | - | $2.68 M(-236.8%) | -$3.35 M(-59.4%) |
| June 2019 | - | -$1.96 M(-9.6%) | -$8.26 M(-11.3%) |
| Mar 2019 | - | -$2.17 M(+13.4%) | -$9.32 M(-19.0%) |
| Dec 2018 | -$8.76 M(-57.6%) | -$1.91 M(-14.2%) | -$11.51 M(-13.0%) |
| Sept 2018 | - | -$2.23 M(-26.2%) | -$13.22 M(-13.8%) |
| June 2018 | - | -$3.02 M(-30.7%) | -$15.34 M(-14.3%) |
| Mar 2018 | - | -$4.35 M(+19.9%) | -$17.91 M(-13.4%) |
| Dec 2017 | -$20.68 M(+5.0%) | -$3.63 M(-16.4%) | -$20.68 M(+0.2%) |
| Sept 2017 | - | -$4.34 M(-22.2%) | -$20.64 M(-2.2%) |
| June 2017 | - | -$5.58 M(-21.7%) | -$21.10 M(-3.0%) |
| Mar 2017 | - | -$7.13 M(+98.6%) | -$21.74 M(+10.3%) |
| Dec 2016 | -$19.71 M(-14.2%) | -$3.59 M(-25.2%) | -$19.71 M(-5.6%) |
| Sept 2016 | - | -$4.80 M(-22.9%) | -$20.88 M(-2.4%) |
| June 2016 | - | -$6.22 M(+22.1%) | -$21.39 M(-4.9%) |
| Mar 2016 | - | -$5.10 M(+7.1%) | -$22.50 M(-2.0%) |
| Dec 2015 | -$22.95 M(-30.0%) | -$4.76 M(-10.4%) | -$22.95 M(+0.9%) |
| Sept 2015 | - | -$5.31 M(-27.5%) | -$22.75 M(-10.6%) |
| June 2015 | - | -$7.33 M(+32.0%) | -$25.46 M(-11.6%) |
| Mar 2015 | - | -$5.55 M(+22.0%) | -$28.81 M(-12.2%) |
| Dec 2014 | -$32.81 M(-1.6%) | -$4.55 M(-43.3%) | -$32.81 M(-12.2%) |
| Sept 2014 | - | -$8.02 M(-24.9%) | -$37.37 M(-1.2%) |
| June 2014 | - | -$10.69 M(+11.9%) | -$37.81 M(+4.8%) |
| Mar 2014 | - | -$9.55 M(+4.7%) | -$36.07 M(+8.2%) |
| Dec 2013 | -$33.35 M(+17.9%) | -$9.12 M(+7.8%) | -$33.35 M(+16.6%) |
| Sept 2013 | - | -$8.46 M(-5.4%) | -$28.59 M(-2.4%) |
| June 2013 | - | -$8.95 M(+31.2%) | -$29.30 M(+10.1%) |
| Mar 2013 | - | -$6.82 M(+56.3%) | -$26.60 M(-6.0%) |
| Dec 2012 | -$28.29 M | -$4.36 M(-52.4%) | -$28.29 M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$9.17 M(+46.7%) | -$30.48 M(+1.3%) |
| June 2012 | - | -$6.25 M(-26.5%) | -$30.10 M(-10.1%) |
| Mar 2012 | - | -$8.51 M(+29.7%) | -$33.47 M(+1.3%) |
| Dec 2011 | -$33.03 M(+24.3%) | -$6.56 M(-25.4%) | -$33.03 M(-9.1%) |
| Sept 2011 | - | -$8.79 M(-8.6%) | -$36.34 M(-2.2%) |
| June 2011 | - | -$9.62 M(+19.3%) | -$37.14 M(+14.1%) |
| Mar 2011 | - | -$8.06 M(-18.3%) | -$32.56 M(+22.5%) |
| Dec 2010 | -$26.58 M(+23.3%) | -$9.87 M(+2.9%) | -$26.58 M(+3.1%) |
| Sept 2010 | - | -$9.59 M(+90.2%) | -$25.78 M(+14.0%) |
| June 2010 | - | -$5.04 M(+142.9%) | -$22.61 M(+25.6%) |
| Mar 2010 | - | -$2.08 M(-77.1%) | -$18.00 M(-16.4%) |
| Dec 2009 | -$21.55 M(-27.6%) | -$9.07 M(+41.2%) | -$21.52 M(+15.1%) |
| Sept 2009 | - | -$6.42 M(+1397.4%) | -$18.71 M(-5.2%) |
| June 2009 | - | -$429.00 K(-92.3%) | -$19.74 M(-28.7%) |
| Mar 2009 | - | -$5.60 M(-10.4%) | -$27.68 M(-9.0%) |
| Dec 2008 | -$29.76 M(-5.1%) | -$6.25 M(-16.2%) | -$30.41 M(-24.4%) |
| Sept 2008 | - | -$7.46 M(-10.9%) | -$40.20 M(+4.8%) |
| June 2008 | - | -$8.37 M(+0.5%) | -$38.36 M(+6.2%) |
| Mar 2008 | - | -$8.33 M(-48.1%) | -$36.10 M(-1.3%) |
| Dec 2007 | -$31.35 M(+61.8%) | -$16.05 M(+186.1%) | -$36.58 M(+127.5%) |
| Sept 2007 | - | -$5.61 M(-8.3%) | -$16.08 M(-16.8%) |
| June 2007 | - | -$6.12 M(-30.6%) | -$19.34 M(-6.3%) |
| Mar 2007 | - | -$8.81 M(-297.8%) | -$20.65 M(+6.5%) |
| Dec 2006 | -$19.38 M(-29.9%) | $4.45 M(-150.2%) | -$19.38 M(-42.5%) |
| Sept 2006 | - | -$8.87 M(+19.4%) | -$33.71 M(+3.1%) |
| June 2006 | - | -$7.42 M(-1.5%) | -$32.71 M(+6.8%) |
| Mar 2006 | - | -$7.54 M(-23.7%) | -$30.64 M(+10.9%) |
| Dec 2005 | -$27.63 M(+78.7%) | -$9.88 M(+25.5%) | -$27.63 M(+26.3%) |
| Sept 2005 | - | -$7.87 M(+47.1%) | -$21.87 M(+19.3%) |
| June 2005 | - | -$5.35 M(+18.1%) | -$18.33 M(+9.6%) |
| Mar 2005 | - | -$4.53 M(+9.8%) | -$16.73 M(+6.5%) |
| Dec 2004 | -$15.46 M(+67.9%) | -$4.12 M(-4.7%) | -$15.70 M(+22.8%) |
| Sept 2004 | - | -$4.33 M(+15.3%) | -$12.79 M(+17.5%) |
| June 2004 | - | -$3.75 M(+7.0%) | -$10.89 M(+17.1%) |
| Mar 2004 | - | -$3.50 M(+189.1%) | -$9.30 M(+0.9%) |
| Dec 2003 | -$9.21 M(-19.9%) | -$1.21 M(-50.0%) | -$9.21 M(-20.3%) |
| Sept 2003 | - | -$2.42 M(+12.3%) | -$11.56 M(-4.3%) |
| June 2003 | - | -$2.16 M(-36.8%) | -$12.08 M(+2.9%) |
| Mar 2003 | - | -$3.42 M(-4.2%) | -$11.74 M(+2.1%) |
| Dec 2002 | -$11.50 M(+0.6%) | -$3.56 M(+21.3%) | -$11.50 M(+23.4%) |
| Sept 2002 | - | -$2.94 M(+61.7%) | -$9.32 M(-2.8%) |
| June 2002 | - | -$1.82 M(-42.8%) | -$9.59 M(-24.6%) |
| Mar 2002 | - | -$3.18 M(+129.0%) | -$12.71 M(+33.3%) |
| Dec 2001 | -$11.43 M(+19.0%) | -$1.39 M(-56.7%) | -$9.53 M(+17.0%) |
| Sept 2001 | - | -$3.20 M(-35.2%) | -$8.14 M(+64.8%) |
| June 2001 | - | -$4.94 M | -$4.94 M |
| Dec 2000 | -$9.61 M(+114.7%) | - | - |
| Dec 1999 | -$4.47 M(+117.5%) | - | - |
| Dec 1998 | -$2.06 M | - | - |
FAQ
- What is Plus Therapeutics annual operaing income?
- What is the all time high annual operating profit for Plus Therapeutics?
- What is Plus Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Plus Therapeutics?
- What is Plus Therapeutics quarterly operating profit year-on-year change?
- What is Plus Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Plus Therapeutics?
- What is Plus Therapeutics TTM operating profit year-on-year change?
What is Plus Therapeutics annual operaing income?
The current annual operating profit of PSTV is -$13.32 M
What is the all time high annual operating profit for Plus Therapeutics?
Plus Therapeutics all-time high annual operaing income is -$2.06 M
What is Plus Therapeutics quarterly operating income?
The current quarterly operating profit of PSTV is -$3.80 M
What is the all time high quarterly operating profit for Plus Therapeutics?
Plus Therapeutics all-time high quarterly operating income is $4.45 M
What is Plus Therapeutics quarterly operating profit year-on-year change?
Over the past year, PSTV quarterly operating income has changed by +$59.00 K (+1.53%)
What is Plus Therapeutics TTM operating income?
The current TTM operating profit of PSTV is -$14.65 M
What is the all time high TTM operating profit for Plus Therapeutics?
Plus Therapeutics all-time high TTM operating income is -$3.35 M
What is Plus Therapeutics TTM operating profit year-on-year change?
Over the past year, PSTV TTM operating income has changed by -$1.33 M (-10.00%)